Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Androtriol Injection in Acute Ischemic Stroke
ChiCTR2400088887Phase 2Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Experimental – Androtriol injection with Placebo – Hydroxypropyl-beta-cyclodextrin injection (2 arms). Primary endpoints: Distribution of modified Rankin Scale (mRS) score at 90 days after randomization and Midline shift (mm) at 72h and 10d after randomization compared with 24h. Started Aug 2024; status: completed.
02
Drugs
androtriol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400088887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088887.